1: \begin{abstract}

2: We examine nonparametric dose-finding designs that use toxicity estimates based on all available data at each dose allocation decision. We prove that one such design family, called here ``interval design'', converges almost surely to the maximum tolerated dose (MTD), if the MTD is the only dose level whose toxicity rate falls within the pre-specified interval around the desired target rate. Another nonparametric family, called ``point design'', has a positive probability of not converging. In a numerical sensitivity study, a diverse sample of dose-toxicity scenarios was randomly generated. On this sample, the ``interval design'' convergence conditions are met far more often than the conditions for one-parameter design convergence (the Shen-O'Quigley conditions), suggesting that the interval-design conditions are less restrictive. Implications of these theoretical and numerical results for small-sample behavior of the designs, and for future research, are discussed.

3: 

4: %\begin{keywords}

5: Keywords: Adaptive Designs, Continual Reassessment Method, Dose Finding, Phase I clinical trials, Cumulative Cohort Design, Up-and-Down

6: 

7: \end{abstract}